Estrogen receptor-α signaling in post-natal mammary development and breast cancers | SpringerLink
Estrogen Receptors: How Do They Signal and What Are Their Targets | Physiological Reviews
Transrepression of estrogen receptor and NFκB. (a) NFκB can inhibit... | Download Scientific Diagram
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
IJMS | Free Full-Text | The Role of ERα36 in Development and Tumor Malignancy | HTML
Estrogen signaling: An emanating therapeutic target for breast cancer treatment - ScienceDirect
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer
Dual-mechanism estrogen receptor inhibitors | PNAS
Impact of Apparent Antagonism of Estrogen Receptor β by Fulvestrant on Anticancer Activity of 2-Methoxyestradiol | Anticancer Research
Estrogen Receptor Pathway | Progestogen Rectieptor Signaling
Potentiation of ICI182,780 (Fulvestrant)-induced Estrogen Receptor-α Degradation by the Estrogen Receptor-related Receptor-α Inverse Agonist XCT790* - Journal of Biological Chemistry
Estrogen receptor functional domains and signal transduction schemes.... | Download Scientific Diagram
Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer
Dual-mechanism estrogen receptor inhibitors | PNAS
Dual-mechanism estrogen receptor inhibitors | PNAS
IJMS | Free Full-Text | Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers | HTML
Frontiers | Involvement of the Estrogen and Progesterone Axis in Cancer Stemness: Elucidating Molecular Mechanisms and Clinical Significance
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling
Cross-talk between nuclear receptors and nuclear factor κB | Oncogene
Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer | Journal of Medicinal Chemistry
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer | Breast Cancer Research | Full Text
EREs).
New insights into acquired endocrine resistance of breast cancer
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
